Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors

被引：0
|
作者：
Elina Uusitalo
Roope A Kallionpää
Samu Kurki
Matti Rantanen
Janne Pitkäniemi
Pauliina Kronqvist
Pirkko Härkönen
Riikka Huovinen
Olli Carpen
Minna Pöyhönen
Sirkku Peltonen
Juha Peltonen
机构：
[1] University of Turku,Department of Cell Biology and Anatomy
[2] Auria Biobank,Department of Public Health
[3] University of Turku and Turku University Hospital,Department of Pathology
[4] Finnish Cancer Registry–Institute for Statistical and Epidemiological Cancer Research,Department of Oncology and Radiotherapy
[5] Faculty of Medicine,Department of Pathology
[6] University of Helsinki,Department of Clinical Genetics
[7] University of Turku and Turku University Hospital,Department of Medical and Clinical Genetics
[8] Turku University Hospital,Department of Dermatology
[9] University of Helsinki and Helsinki University Hospital,undefined
[10] HUSLAB,undefined
[11] Helsinki University Central Hospital,undefined
[12] University of Helsinki,undefined
[13] University of Turku and Turku University Hospital,undefined
来源：
British Journal of Cancer | 2017年 / 116卷
关键词：
breast cancer; cancer syndrome; RASopathy; tumour suppressor; histopathology; hormone receptors; survival; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：211 / 217
页数：6
相关论文
共 50 条
  • [21] Prognostic factors in breast cancer
    Sanal, SM
    Sanli, U
    Gokmen, E
    2ND BALKAN CONGRESS OF ONCOLOGY, 1999, : 143 - 148
  • [22] PROGNOSTIC FACTORS IN BREAST CANCER
    Georgescu, R.
    Coros, M. F.
    Stolnicu, Simona
    Podeanu, Daniela
    Sorlea, S.
    Rosca, Anca
    Copotoiu, C.
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2012, 116 (01): : 262 - 267
  • [23] PNPT1 is an unfavourable prognostic biomarker in lymphatic cancer
    Ventura, I.
    Prieto-Ruiz, J. A.
    Lizanda, M.
    Revert, F.
    Revert-Ros, F.
    Gomez-Tatay, L.
    Hernandez-Andreu, J. M.
    FEBS OPEN BIO, 2022, 12 : 85 - 86
  • [24] Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer
    Pinto, AE
    Andre, S
    Nogueira, M
    Mendonca, E
    Soares, J
    JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (07) : 591 - 595
  • [25] Breast cancer in a patient with neurofibromatosis type 1: A case report and review of literature
    Canice Nwagbara, Victor, I
    Ashindoitiang, John A.
    Ugbem, Theophilus Ipeh
    Magam, Dino N.
    Meremikwu, Chibuike M.
    Nnalue, Victor D.
    Asuquo, Maurice E.
    RARE TUMORS, 2025, 17
  • [26] Age-specific risk of breast cancer in women with neurofibromatosis type 1
    O O Seminog
    M J Goldacre
    British Journal of Cancer, 2015, 112 : 1546 - 1548
  • [27] Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity
    Suarez-Kelly, Lorena P.
    Akagi, Keiko
    Reeser, Julie W.
    Samorodnitsky, Eric
    Reeder, Matthew
    Smith, Amy
    Roychowdhury, Sameek
    Symer, David E.
    Carson, William E.
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2018, 4 (02):
  • [28] Age-specific risk of breast cancer in women with neurofibromatosis type 1
    Seminog, O. O.
    Goldacre, M. J.
    BRITISH JOURNAL OF CANCER, 2015, 112 (09) : 1546 - 1548
  • [29] Breast cancer associated with neurofibromatosis type 1: A case series and review of the literature
    Khalil J.
    Afif M.
    Elkacemi H.
    Benoulaid M.
    Kebdani T.
    Benjaafar N.
    Journal of Medical Case Reports, 9 (1)
  • [30] Neurofibroma of the breast in a boy with neurofibromatosis type 1
    Murat, A
    Kansiz, F
    Kabakus, N
    Kazez, A
    Ozercan, R
    CLINICAL IMAGING, 2004, 28 (06) : 415 - 417
12345